MPLT logo

MPLT
MapLight Therapeutics Inc.

91
Mkt Cap
$1.13B
Volume
437,082.00
52W High
$30.28
52W Low
$12.24
PE Ratio
-7.20
MPLT Fundamentals
Price
$26.73
Prev Close
$29.41
Open
$29.51
50D MA
$18.81
Beta
2.07
Avg. Volume
228,140.10
EPS (Annual)
-$3.66
P/B
2.57
Rev/Employee
$0.00
$473.98
Loading...
Loading...
News
all
press releases
Maplight Therapeutics (NASDAQ:MPLT) Trading Down 6.9% - Time to Sell?
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Down 6.9% - Should You Sell...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Trading 8.2% Higher - Still a Buy?
Maplight Therapeutics (NASDAQ:MPLT) Trading Up 8.2% - Here's Why...
MarketBeat·3d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Earns Buy Rating from Analysts at Needham & Company LLC
Needham & Company LLC assumed coverage on Maplight Therapeutics in a research report on Wednesday. They set a "buy" rating and a $37.00 target price for the company...
MarketBeat·4d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Hits New 52-Week High - Should You Buy?
Maplight Therapeutics (NASDAQ:MPLT) Hits New 1-Year High - Still a Buy...
MarketBeat·4d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Coverage Initiated at TD Cowen
TD Cowen started coverage on shares of Maplight Therapeutics in a research note on Tuesday. They issued a "buy" rating for the company...
MarketBeat·5d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Reaches New 52-Week High - Here's Why
Maplight Therapeutics (NASDAQ:MPLT) Reaches New 12-Month High - What's Next...
MarketBeat·10d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Issues Quarterly Earnings Results, Misses Estimates By $1.42 EPS
Maplight Therapeutics (NASDAQ:MPLT - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($2.47) EPS for the quarter, missing the consensus estimate of ($1.05) by ($1.42...
MarketBeat·16d ago
News Placeholder
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Given Average Recommendation of "Moderate Buy" by Analysts
Maplight Therapeutics, Inc. (NASDAQ:MPLT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven research firms that are presently covering the firm, MarketBeat...
MarketBeat·16d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Shares Up 5.6% - What's Next?
Maplight Therapeutics (NASDAQ:MPLT) Shares Up 5.6% - Still a Buy...
MarketBeat·17d ago
News Placeholder
Maplight Therapeutics (NASDAQ:MPLT) Cut to Sell at Wall Street Zen
Wall Street Zen downgraded Maplight Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·23d ago
<
1
2
...
>

Latest MPLT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.